Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/WINT · Entity 8761 | Director | February 03, 2021 | February 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
WINDTREE THERAPEUTICS INC /DE/
Report date February 03, 2021 · Filed February 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.50 · Expires 2031-02-03 | Direct | 15,000 |
Reported balance
After 2021-02-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-02-03 · Grant · Acquired 15,000 · Balance 15,000 F1: The stock options were fully vested and exercisable on the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 2,069 |
Reported balance
Holding disclosure · report date 2021-02-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,069 |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were fully vested and exercisable on the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2021 Filed Feb 6, 2021 02:09 UTC | WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-21-002146 · rdgdoc.xml · derivative · entry 2 Schreiber Brian D · CIK 0001762945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock options were fully vested and exercisable on the grant date. Read SEC document |
| May 22, 2020 Filed May 28, 2020 01:43 UTC | WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761 | PurchaseCommon Stock Warrants · Derivative | 2,069 | $0.00 Strike: $7.98 | $0.00 |
DisclosureSEC source: 0001437749-20-011872 · rdgdoc.xml · derivative · entry 2 Schreiber Brian D · CIK 0001762945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,069 Underlying: Common Stock · 2,069 shares Expires 2025-05-22 F1 · price: Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above. Read SEC document |
| May 22, 2020 Filed May 28, 2020 01:43 UTC | WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761 | PurchaseCommon Stock | 2,069 | $7.25 | $15,000.25 |
DisclosureSEC source: 0001437749-20-011872 · rdgdoc.xml · nonDerivative · entry 1 Schreiber Brian D · CIK 0001762945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,069 Read SEC document |
| April 24, 2019 Filed Apr 26, 2019 21:36 UTC | WINDTREE THERAPEUTICS INC /DE/ WINT · Entity 8761 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001437749-19-008086 · rdgdoc.xml · derivative · entry 1 Schreiber Brian D · CIK 0001762945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-04-24 F1 · derivative.exercise_date: This stock option shall vest in a series of three successive, equal installments measured from the date of Dr. Schreiber's appointment to the Board of Directors on December 21, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.